期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 515, 期 1-2, 页码 331-342出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2016.10.031
关键词
Nanomedicine; Theranostics; Blood brain barrier; Drug delivery; Imaging
资金
- Lidow Senior Thesis Fund
The blood brain barrier (BBB) is a major obstacle to drug delivery for diseases of the central nervous system (CNS). This brief review highlights the current invasive and non-invasive technologies available to address this problem. In particular, nanomedicine has shown much promise as a non-invasive strategy due to its drug loading capabilities, ease of targeting to the BBB, and small size. The versatility of this technology in terms of type of drug and imaging agent, carrier material, and targeting mechanism is highlighted in this review. The recent inclusion of imaging agents in the nanocarriers has important consequences for the field of theranostics. (C) 2016 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据